Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Albireo Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 109 | 3 | 103 | −3 |
| Shares | 16.6M | 79.6K | 17.8M | +1.31M (+7.9%) |
| Value | $495.4M | $2.38M | $352.6M | −$140.4M (−28.5%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Albireo Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 231,278 | $4.59M | 0.36% |
| Qube Research & Technologies Ltd | 54,015 | $1.07M | 0.01% |
| Fiera Capital Corp | 53,398 | $1.06M | 0.00% |
| ExodusPoint Capital Management, LP | 52,905 | $1.05M | 0.01% |
| DekaBank Deutsche Girozentrale | 35,000 | $654.0K | 0.00% |
| UBS Oconnor LLC | 30,401 | $604.0K | 0.01% |
| Victory Capital Management Inc | 22,380 | $444.0K | 0.00% |
| Principal Financial Group Inc | 19,429 | $386.0K | 0.00% |
| SG Americas Securities, LLC | 10,867 | $216.0K | 0.00% |
| Gsa Capital Partners LLP | 10,079 | $200.0K | 0.03% |
| Simplex Trading, LLC | 5,694 | $113.0K | 0.00% |
| Caption Management, LLC | 4,300 | $85.0K | 0.01% |
| Aquatic Capital Management LLC | 1,200 | $24.0K | 0.01% |
| Quantbot Technologies LP | 145 | $2.00K | 0.00% |
| Signaturefd, LLC | 58 | $1.00K | 0.00% |
| Quadrant Capital Group LLC | 38 | $1.00K | 0.00% |
| Glassman Wealth Services | 9 | $0 | 0.00% |
| Parallel Advisors, LLC | 9 | $0 | 0.00% |
Sold out (21)
Institutions that held Albireo Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 194,000 | $5.79M |
| Point72 Asset Management, L.P. | 169,600 | $5.06M |
| Silver Oak Securities, Inc | 23,795 | $836.0K |
| Los Angeles Capital Management LLC | 20,553 | $613.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 18,197 | $543.0K |
| HRT Financial LP | 13,239 | $394.0K |
| State Board of Administration of Florida Retirement System | 13,059 | $390.0K |
| Cubist Systematic Strategies, LLC | 10,975 | $327.0K |
| AdvisorShares Investments LLC | 9,066 | $270.0K |
| Ergoteles LLC | 8,288 | $247.0K |
| Grimes & Company, Inc. | 8,191 | $244.0K |
| Burney Co | 7,976 | $238.0K |
| Manufacturers Life Insurance Company, The | 7,434 | $221.8K |
| UBS Asset Management Americas Inc | 7,337 | $218.9K |
| Invesco Ltd. | 6,780 | $203.0K |
| Voya Investment Management LLC | 6,772 | $202.0K |
| Lazard Asset Management LLC | 2,532 | $75.0K |
| Point72 Hong Kong Ltd | 662 | $20.0K |
| TCI Wealth Advisors, Inc. | 189 | $6.00K |
| Tarbox Family Office, Inc. | 50 | $1.00K |
| State of Wyoming | 7 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Albireo Pharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 63,616 | $1.90M |
| Susquehanna Fundamental Investments, LLC | 13,394 | $400.0K |
| Amalgamated Financial Corp. | 2,602 | $78.0K |